Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Arteriotomy Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. Arteriotomy closure devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Arteriotomy Closure Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Arteriotomy Closure Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Arteriotomy Closure Devices Overview
Products under Development
Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Table Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Table Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Arteriotomy Closure Devices - Pipeline Products by Segment
Table Arteriotomy Closure Devices - Pipeline Products by Segment
Table Arteriotomy Closure Devices - Pipeline Products by Segment
Arteriotomy Closure Devices - Pipeline Products by Territory
Table Arteriotomy Closure Devices - Pipeline Products by Territory
Table Arteriotomy Closure Devices - Pipeline Products by Territory
Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Table Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Table Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Table Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Table Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Table SureClose Vascular Closure Device - Clinical First in Man Study of the Safety and Performance of the Genesis Medtech Innovation Private Limited Sureclose Vascular Closure Device (VCD) for use In Closing Femoral Access Sites
Harvard University Company Overview
Harvard University Pipeline Products & Ongoing Clinical Trials Overview
Table Harvard University Pipeline Products & Ongoing Clinical Trials Overview
Table Access-Closure Device - Product Status
Table Access-Closure Device - Product Description
Lepu Medical Technology (Beijing) Co Ltd Company Overview
Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Vascular Closure Device System - Product Status
Table Vascular Closure Device System - Product Description
Nanjing SealMed Medical Technology Corp Ltd Company Overview
Table Vivasure Medical Ltd. - Ongoing Clinical Trials Overview
Table PerQseal - A Multicentre, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the Vivasure PerQseal Closure Device System When Used to Achieve Haemostasis of Common Femoral Arteriotomies Created by 12 to 22 F Sheaths in Patients Undergoing Percutaneous Catheter-Based Interventional Procedures
Table PerQseal+ - An Early Feasibility Study Evaluating the Safety and Efficacy of PerQseal+ in Patients Undergoing Percutaneous Transcatheter Aortic Valve Replacement Procedures
Table PerQseal+ - Clinical Investigation Plan (CIP) for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study
Table PerQseal ELITE - Clinical Investigation Plan (CIP) for: Safety and Performance Study for Arterial Large Hole Vascular Closure Device - ELITE Study
Table PerQseal ELITE - Safety and Performance Study for Venous Large Hole Vascular Closure Device - ELITE Study
Zylox-Tonbridge Medical Technology Co Ltd Company Overview
Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Suture-Mediated Closure System - Product Status
Table Suture-Mediated Closure System - Product Description
Table Zylox-Tonbridge Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table Suture-Mediated Closure System - A Prospective, Multi-center, Randomized Controlled, Non-inferiority Clinical Trial of the Safety and Efficacy of the Suture-Mediated Closure System for Percutaneous Closure of the Common Femoral Artery Puncture Site
Table Suture-Mediated Closure System - Multi-center, Randomized and Non-inferiority Clinical Trial to Assess Efficacy and Safety of Suture-mediated Closure system
Arteriotomy Closure Devices- Recent Developments
Apr 15, 2024: Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System
Dec 12, 2023: Vivasure Medical Announces First Patients Treated with PerQseal Elite Closure Device System
Nov 17, 2023: Teleflex enrols first patient in MANTA device trial
Nov 14, 2023: Vivasure Medical Announces 100th Patient Enrolled in U.S. Pivotal Study
Aug 29, 2023: Haemonetics Announces European Expansion for VASCADE Vascular Closure System